To examine the characteristics of positive staining for p53 protein in bladder tumours systematically, we evaluated both p53 mutation and immunohistochemical staining of p53 in a population-based sample of bladder cancers from inhabitants of New Hampshire. This evidence concerns the gene TP53 and urinary bladder carcinoma.